Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $645.0 million public offering of 5,972,222 shares of common stock by Kodiak Sciences Inc., which includes 778,985 shares from the full exercise of the underwriters’ option to purchase additional shares. The common stock is listed on the Nasdaq Global Select Market under the symbol “KOD.”

Kodiak is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases.

The Davis Polk corporate team included partners Alan F. Denenberg and Emily Roberts and associates Dongbiao Shen and Claire A. Bacon. Counsel Kiara L. Rankin and associate Ben Levenback provided tax advice. Counsel Bonnie Chen and associate Shuang Ci provided intellectual property advice. Members of the Davis Polk team are based in the Northern California and New York offices.

Copy link to share post